Is ACADIA Pharmaceuticals Inc. overvalued?

ACADIA Pharmaceuticals Inc. (ACAD) looks undervalued — trading about 14% below its fair value.

Undervalued

Price

$20.68

Fair value

$23.49

Current P/E

10.1

Normal P/E

11.5

Market cap

$3.54B

Dividend yield

0.0%

Return on equity

32.4%

Sector

Healthcare

Fair value compares ACAD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks